Thompson GR - Search Results

1

Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry.

Scoppola A, Maher VM, Thompson GR, Rendell NB, Taylor GW. Scoppola A, et al. Among authors: thompson gr. J Lipid Res. 1991 Jun;32(6):1057-60. J Lipid Res. 1991. PMID: 1940620 Free article.

2

Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia.

Maher VM, Trainer PJ, Scoppola A, Anderson JV, Thompson GR, Besser GM. Maher VM, et al. Among authors: thompson gr. Q J Med. 1992 Sep;84(305):671-9. Q J Med. 1992. PMID: 1480741

3

HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.

Maher VM, Thompson GR. Maher VM, et al. Among authors: thompson gr. Q J Med. 1990 Feb;74(274):165-75. Q J Med. 1990. PMID: 2111917 Clinical Trial.

4

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.

Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. Among authors: thompson gr. Atherosclerosis. 1996 Jan 26;119(2):203-13. doi: 10.1016/0021-9150(95)05649-1. Atherosclerosis. 1996. PMID: 8808497

5

Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin.

Naoumova RP, Dunn S, Rallidis L, Abu-Muhana O, Neuwirth C, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. Among authors: thompson gr. J Lipid Res. 1997 Jul;38(7):1496-500. J Lipid Res. 1997. PMID: 9254075 Free article. Clinical Trial.

6

Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.

Maher VM, Gallagher JJ, Thompson GR, Myant NB. Maher VM, et al. Among authors: thompson gr. Atherosclerosis. 1991 Nov;91(1-2):73-6. doi: 10.1016/0021-9150(91)90188-9. Atherosclerosis. 1991. PMID: 1811555

7

Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.

Naoumova RP, Cummings MH, Watts GF, Rendell NB, Taylor GW, Sönksen PH, Thompson GR. Naoumova RP, et al. Among authors: thompson gr. Eur J Clin Invest. 1996 Apr;26(4):332-40. doi: 10.1046/j.1365-2362.1996.138285.x. Eur J Clin Invest. 1996. PMID: 8732493 Clinical Trial.

8

Cholesterol synthesis is increased in mixed hyperlipidaemia.

Naoumova RP, Kim KD, Neuwirth C, Niththyananthan S, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. Among authors: thompson gr. Biochim Biophys Acta. 1998 Nov 2;1394(2-3):146-52. doi: 10.1016/s0005-2760(98)00103-9. Biochim Biophys Acta. 1998. PMID: 9795192

9

Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway.

Naoumova RP, O'Neill FH, Dunn S, Neuwirth CK, Taylor GW, Axelson M, Thompson GR. Naoumova RP, et al. Among authors: thompson gr. Eur J Clin Invest. 1999 May;29(5):404-12. doi: 10.1046/j.1365-2362.1999.00475.x. Eur J Clin Invest. 1999. PMID: 10354197 Clinical Trial.

10

Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia.

O'Neill FH, Patel DD, Knight BL, Neuwirth CK, Bourbon M, Soutar AK, Taylor GW, Thompson GR, Naoumova RP. O'Neill FH, et al. Among authors: thompson gr. Arterioscler Thromb Vasc Biol. 2001 May;21(5):832-7. doi: 10.1161/01.atv.21.5.832. Arterioscler Thromb Vasc Biol. 2001. PMID: 11348882 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

584 results

Search Page

Filters